What is a suitable oral dose of hydralazine (direct vasodilator) if 10mg intravenous (IV) administration is not feasible?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Hydralazine Dosing When IV Administration is Not Feasible

When IV hydralazine 10 mg cannot be administered due to lack of venous access, an oral hydralazine dose of 25-50 mg should be used as an appropriate substitute. 1

Pharmacokinetics and Bioavailability Considerations

  • Hydralazine has lower bioavailability when administered orally (26-55% of the dose reaches systemic circulation as unchanged drug) due to first-pass metabolism 2
  • Oral hydralazine undergoes extensive hepatic metabolism with peak plasma levels reached at 1-2 hours after administration 3
  • The half-life of hydralazine is 3-7 hours, with significant variability among individuals due to polymorphic acetylation (slow acetylators generally have higher plasma levels) 3

Dosing Recommendations

Initial Oral Dosing

  • For acute management when IV administration is not possible:
    • Start with 25-50 mg oral hydralazine 1
    • This corresponds to the initial oral dosing range recommended in heart failure guidelines 1

Maintenance Dosing

  • For ongoing management:
    • Typical oral dosing is 25-50 mg three to four times daily 1
    • Target total daily dose ranges from 100-300 mg divided into multiple doses 1
    • The mean total daily dose achieved in clinical trials for heart failure was 175 mg 1

Clinical Considerations and Precautions

Onset and Duration of Action

  • Blood pressure begins to decrease within 10-30 minutes after IV administration, with effects lasting 2-4 hours 1
  • Oral administration will have a somewhat delayed onset compared to IV administration 3
  • The unpredictability of response and prolonged duration of action make hydralazine less desirable as a first-line agent for acute hypertension management 1

Adverse Effects and Monitoring

  • Common adverse effects include reflex tachycardia due to peripheral vasodilation 4
  • Serious but less common adverse effects include:
    • Lupus-like syndrome with prolonged use 3
    • Blood dyscrasias (reduction in hemoglobin, leukopenia, agranulocytosis) 3
  • Monitor for excessive hypotension, especially when combined with other antihypertensive medications 3

Special Considerations

  • Tolerance to the vasodilator effect may develop during long-term oral therapy, potentially reducing efficacy 5
  • Food increases plasma levels of hydralazine, which may affect dosing considerations 3
  • Hydralazine is available in 10 mg, 25 mg, 50 mg, and 100 mg oral tablet formulations 3

Practical Algorithm for Oral Substitution of IV Hydralazine

  1. For acute management when 10 mg IV hydralazine would be indicated:

    • Administer 25-50 mg oral hydralazine 1
    • Monitor blood pressure response within 1-2 hours (time to peak plasma levels) 3
  2. If additional doses are needed:

    • May repeat 25-50 mg every 4-6 hours as needed 1
    • Do not exceed 300 mg total daily dose 1
  3. For transition to maintenance therapy:

    • Convert to a regular dosing schedule of 25-50 mg three to four times daily 1
    • Adjust based on blood pressure response and tolerability 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Studies on hydralazine. III. Bioavailability of hydralazine in man.

European journal of clinical pharmacology, 1976

Research

Hydralazine for essential hypertension.

The Cochrane database of systematic reviews, 2011

Research

Acquired tolerance to dilator action of hydrallazine during oral administration.

British journal of clinical pharmacology, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.